NO20032458L - Screeningsanalyse for antagonister av humane leukocytreseptorer - Google Patents

Screeningsanalyse for antagonister av humane leukocytreseptorer

Info

Publication number
NO20032458L
NO20032458L NO20032458A NO20032458A NO20032458L NO 20032458 L NO20032458 L NO 20032458L NO 20032458 A NO20032458 A NO 20032458A NO 20032458 A NO20032458 A NO 20032458A NO 20032458 L NO20032458 L NO 20032458L
Authority
NO
Norway
Prior art keywords
antagonists
screening assay
human leukocyte
leukocyte receptors
receptors
Prior art date
Application number
NO20032458A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032458D0 (no
Inventor
Zhenyi Xu
K M Erik Michaelsson
Leif Petersson
Poul Soerensen
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Publication of NO20032458D0 publication Critical patent/NO20032458D0/no
Publication of NO20032458L publication Critical patent/NO20032458L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/5052—Cells of the immune system involving B-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20032458A 2000-12-22 2003-05-30 Screeningsanalyse for antagonister av humane leukocytreseptorer NO20032458L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0004781A SE0004781D0 (sv) 2000-12-22 2000-12-22 A screening assay for antagonists of human leukocyte receptors
PCT/SE2001/002841 WO2002052268A1 (fr) 2000-12-22 2001-12-20 Dosage biologique d'antagonistes de recepteurs de leucocytes humains

Publications (2)

Publication Number Publication Date
NO20032458D0 NO20032458D0 (no) 2003-05-30
NO20032458L true NO20032458L (no) 2003-06-18

Family

ID=20282361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032458A NO20032458L (no) 2000-12-22 2003-05-30 Screeningsanalyse for antagonister av humane leukocytreseptorer

Country Status (9)

Country Link
US (1) US20040106160A1 (fr)
EP (1) EP1344063A1 (fr)
JP (1) JP2004516037A (fr)
CN (1) CN1481504A (fr)
CA (1) CA2436777A1 (fr)
NO (1) NO20032458L (fr)
RU (1) RU2003122348A (fr)
SE (1) SE0004781D0 (fr)
WO (1) WO2002052268A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201104950D0 (en) * 2011-03-24 2011-05-11 Univ Birmingham Immune assay
CN104977237B (zh) * 2015-07-01 2018-02-23 北京理工大学 一种原位检测单个活细胞内细胞器中co2生成速率的方法
CN113981031A (zh) * 2021-11-01 2022-01-28 山西中医药大学 一种新型t细胞功能检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025712A1 (fr) * 1992-06-15 1993-12-23 The Regents Of The University Of California Test de triage pour l'identification de medicaments immunosuppresseurs
WO1994014065A1 (fr) * 1992-12-14 1994-06-23 Dana-Farber Cancer Institute, Inc. Procedes d'identification et d'utilisation de composes immunodeprimants
EP1095277B1 (fr) * 1998-07-13 2003-01-22 Cellomics, Inc. Systeme destine a un criblage a base de cellules
AU770551B2 (en) * 1998-12-28 2004-02-26 4-Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
FR2788602B1 (fr) * 1999-01-20 2002-06-07 Inst Nat Sante Rech Med Procede de criblage utile pour identifier des ligands potentiels pour un recepteur capable de s'internaliser
US6642249B2 (en) * 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds

Also Published As

Publication number Publication date
NO20032458D0 (no) 2003-05-30
EP1344063A1 (fr) 2003-09-17
SE0004781D0 (sv) 2000-12-22
JP2004516037A (ja) 2004-06-03
RU2003122348A (ru) 2005-01-27
CN1481504A (zh) 2004-03-10
WO2002052268A1 (fr) 2002-07-04
CA2436777A1 (fr) 2002-07-04
US20040106160A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
EE200000778A (et) 4-bensüülpiperidiinalküülsulfoksiidi heterotsüklid ja nende kasutamine NMDA retseptori alaliikide suhtes selektiivsete antagonistidena
DK1638969T3 (da) CGRP-receptorantagonister
DE60106607D1 (de) Substituierte 1-aminoalkyl-lactame und ihre verwendung als muscarinrezeptor antagonisten
PT1157005E (pt) Derivados de 3-fenilpirina e a sua utilizacao como antagonistas do receptor nk-1
ATE346043T1 (de) Il-8-rezeptorantagonisten
NO20025754D0 (no) IL-8 Reseptor-antagonister
PT1131291E (pt) Antagonistas iii do receptor 4-aroil-piperidin-ccr-3
FR2824827B1 (fr) Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
ATE299698T1 (de) Il-8 rezeptor antagonisten
EE200200667A (et) Bitsüklilised tsükloheksüülamiinid ja nende kasutamine NMDA retseptori antagonistidena
DE60238709D1 (de) 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren
DK1261336T3 (da) IL-8-receptorantagonister
DE60224221D1 (de) Aminotetralinderivate, antagonisten von muscarinrezeptoren
MA25739A1 (fr) Antagonistes recepteurs il-8
DK1180028T3 (da) IL-8-receptorantagonister
NO20032458D0 (no) Screeningsanalyse for antagonister av humane leukocytreseptorer
PT1448566E (pt) Antagonistas do receptor quimioquina e metodos de utilizacao do mesmo
MA25659A1 (fr) Antagonistes recepteurs il-8
DE60317632D1 (de) 2-oxazolamine und ihre verwendung als 5-ht2b-rezeptor-antagonisten
NO20015774D0 (no) IL-8 reseptorantagonister
DE60336672D1 (de) Harnstoffderivate als IL-8-Rezeptorantagonisten
DE50106325D1 (de) Liganden von integrinrezeptoren
EE200300335A (et) Histamiiniretseptori antagonistid
FR2824826B1 (fr) Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8
EE200100214A (et) Ureidopiperidiini derivaadid kui inimese NK3 retseptorite selektiivsed antagonistid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application